A new study from Lawson Health Research Institute found that doctors treating brain cancer patients are unclear about reporting requirements. Only 41% of patients were advised not to drive, and only 30% were reported to the Ministry of Transportation, despite brain tumors compromising a patient's ability to safely operate a motor vehicle.
A Category Tree system would categorize products based on tested human studies and health benefits, forcing companies to conduct research or change product labels. This system aims to improve transparency and facilitate further research in North America and Europe.
Dr. Elizabeth Osuch has received a $100,000 grant to improve diagnosis of bipolar disorder in youth through functional brain imaging. The average misdiagnosis often lasts 6-10 years and can lead to declining patient condition if treated with antidepressants.
Dr. Gregor Reid and his team will study the impact of probiotic yogurt on pregnant women and their children in Tanzania to investigate potential benefits for disease prevention. The project aims to understand how nutrition and bacteria can be passed from mothers to their children, a critical period for health development.
Researchers identified a genetic pathway that influences the spread of cancer cells, which could lead to new treatment avenues. The study found that changes in genetics affect DNA methylation, causing cells to divide uncontrollably.
A new study suggests fish oil capsules can reduce AV graft clotting and improve hemodialysis patient outcomes. Patients taking fish oil experienced lower rates of graft failure, cardiovascular events, and blood pressure.
A study by Dr. Arsh Jain found that developing countries are using peritoneal dialysis at a faster rate than developed countries, despite its lower costs and better outcomes. The research highlights the need for increased adoption of this therapy in developed nations.
A new study by Lawson Health Research Institute suggests that intensive kidney dialysis at home can lead to better survival rates, blood pressure results, and biochemical test values compared to conventional dialysis in clinics.
A new study by Lawson Research Institute found that one in 10 older fibrate users experienced a 50% increase in serum creatinine, an indicator of kidney health. The study suggests further research is needed to understand the mechanism behind fibrates' impact on kidney function.
A new study from Lawson Health Research Institute shows that 75% of mental illnesses emerge by age 25. The First Episode Mood and Anxiety Program (FEMAP) provides direct access to specialized services for youth ages 16-26, leading to improved outcomes.
A 10-year study of living kidney donors in Ontario found no increased risk of heart disease compared to the general population. Despite reduced kidney function, donors had a lower risk of death and heart disease than non-donors.
A newly published study found that over a quarter of unexplained cardiac arrests occurred after patients experienced fainting, known as syncope. Patients also exhibited frequent chest pain and palpitations. The research suggests that fainting may be an opportunity to diagnose genetic disorders and prevent future sudden death.
The new hybrid scanner combines MRI and PET technology to capture minute details and produce superior three-dimensional images. It will be used to diagnose cardiovascular disease, neurological diseases, mental health, and cancer more accurately and efficiently.
A new imaging platform has been developed by Lawson researchers to study the moment when cancer cells turn deadly. The approach uses a shell-less chick embryo model implanted with human cancer cells, allowing scientists to modulate and monitor protein effects in real-time.
Scientists at Lawson Research Institute are testing stereotactic ablative radiotherapy (SABR) to treat cancers that spread beyond the original tumor, offering new hope for survival. The COMET Trial aims to assess SABR's impact on patient survival, side effects, and quality of life.
A new study is assessing the feasibility of identifying specific genetic markers in cancer patients' tumours to deliver more targeted treatments. The Lawson research team has developed a process for analyzing tumour DNA to provide a genetic profile report within three weeks, helping oncologists create tailored treatment plans.
A new molecular imaging probe using ghrelin exploits the hunger hormone's unique consumption pattern by malignant prostate cancer cells. The test showed the signal was almost 5 times stronger in malignant cancer cells than in normal or benign cells.
The HealtheSteps program is designed to provide tailored exercise prescriptions and support to residents of Huron County, where rates of cardiovascular disease are higher than average. By engaging with the local community through evidence-based research and community consultations, Dr. Robert Petrella and his team aim to reduce health ...
A recent study by Lawson Research Institute found that nearly half of newly diagnosed Canadian patients with glaucoma were at moderate to advanced stages by the time of diagnosis. The study suggests a lack of preventive screenings and inadequate awareness about risk factors are contributing factors to this issue.
Researchers aim to determine optimal Vitamin C dosing schedule and test therapy in septic patients to moderate organ dysfunction and improve outcomes. A potential new treatment for sepsis may be on the horizon thanks to a significant grant.
Drs. Peter Cadieux and Hassan Razvi have been awarded a $566,000 grant as part of a $2.2 million initiative to explore novel coatings that significantly reduce bacterial adherence to urinary tract stents and catheters. The research aims to improve prevention and treatment of urinary device-associated infections.
Researchers have discovered a dual-action treatment combining steroids within a viscosupplement that provides superior pain relief and improved function. Hydros-TA Joint Therapy shows promise as a next-generation osteoarthritis treatment, offering faster onset and longer-lasting results.
Researchers at Lawson Health Research Institute have found that introducing maspin protein into the nucleus of cancer cells can significantly limit tumor growth and spread. This discovery may lead to new targets for drug development and improved understanding of cancer prognosis.